Salisbury Foundation Trust

FOI_5955

Internal Reference Number: FOI_5955

Date Request Received: 10/12/2020 15:09:33

Date Request Replied To: 13/01/2021 11:54:37

This response was sent via: By Email

Request Summary: usage of antiretroviral therapies

Request Category: Media

 
Question Number 1:
How many patients were treated (for any condition) in the latest 6-month period with the following drugs:
a. Juluca (rilpivirine/dolutegravir)
b. Dovato (lamivudine/dolutegravir)
c. Triumeq (abacavir/lamivudine/dolutegravir)
d. Tivicay (dolutegravir)
e. Isentress (raltegravir)
f. Biktarvy (TAF/emtricitabine/bictegravir)
g. Genvoya (TAF/emtricitabine/elvitegravir/cobisistat)
h. Symtuza (TAF/emtricitabine/darunavir/cobisistat)
i. Odefsey (TAF/emtricitabine/rilpivirine)
j. Descovy (TAF/emtricitabine)
k. Truvada or generic TDF/emtricitabine
 
Answer To Question 1:
a. Juluca (rilpivirine/dolutegravir) : none
b. Dovato (lamivudine/dolutegravir) : none
c. Triumeq (abacavir/lamivudine/dolutegravir) : 33
d. Tivicay (dolutegravir) : 19
e. Isentress (raltegravir) : 15
f. Biktarvy (TAF/emtricitabine/bictegravir) : none
g. Genvoya (TAF/emtricitabine/elvitegravir/cobisistat) : none
h. Symtuza (TAF/emtricitabine/darunavir/cobisistat) : none
i. Odefsey (TAF/emtricitabine/rilpivirine) : 3
j. Descovy (TAF/emtricitabine) : 17
k. Truvada or generic TDF/emtricitabine : 40
 
Question Number 2:
How many patients received any antiretroviral (ART) therapy for HIV treatment (excluding pre-exposure prophylaxis):
a. for the latest 6-month period
b. for the 6 months from July-December 2019
 
Answer To Question 2:
a. for the latest 6-month period : 122
b. for the 6 months from July-December 2019 : 120
 
Question Number 3:
How many patients were treated in the latest 6-months period with Truvada or generic TDF/emtricitabine for:
a. HIV treatment
b. Pre-exposure prophylaxis (PrEP)
 
Answer To Question 3:
a. HIV treatment : 40
b. Pre-exposure prophylaxis (PrEP) : 51
 
Question Number 4:
How many packs of Truvada or generic TDF/emtricitabine were dispensed in latest 6-month period for:
a. HIV treatment
b. Pre-exposure prophylaxis (PrEP)
 
Answer To Question 4:
a. HIV treatment : 160
b. Pre-exposure prophylaxis (PrEP) : 150

This last question is assuming that what they mean by “pack” is a 30 day supply and is also a very rough estimate, however our Pharmacy system does not hold diagnosis.
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values